Does Zurn Elkay’s Expanded US$550 Million Revolver Reshape the Bull Case for ZWS?

Zurn Elkay Water Solutions Corporation -0.18%

Zurn Elkay Water Solutions Corporation

ZWS

45.02

-0.18%

  • On February 19, 2026, Zurn Elkay Water Solutions’ subsidiaries entered into Amendment No. 3 to their first lien credit agreement, refinancing existing revolving borrowings, expanding the revolving credit facility from US$200,000,000 to US$550,000,000, and extending the facility’s maturity to February 19, 2031.
  • The revised agreement, which ties interest margins and fees to net first lien leverage and boosts remaining borrowing capacity to US$540,100,000, materially increases Zurn Elkay’s financial flexibility for future operations or potential initiatives.
  • We’ll now explore how this expanded US$550,000,000 revolving credit facility could influence Zurn Elkay’s investment narrative and perceived financial flexibility.

Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Zurn Elkay Water Solutions Investment Narrative Recap

To own Zurn Elkay, you need to believe in long term demand for water quality and management solutions across non residential construction and infrastructure. The expanded US$550,000,000 revolving credit facility increases financial flexibility, but does not materially change near term catalysts or the key risks around sector exposure, tariff costs, and the potential normalization of growth after pull forward orders.

The most relevant recent announcement here is the company’s Q4 2025 and full year 2025 results, which showed higher sales and net income versus the prior year. Against that backdrop, the much larger credit facility gives Zurn Elkay more room to support ongoing investment in filtration platforms and other growth initiatives if end market conditions and regulatory trends remain supportive.

Yet, investors should also be aware of how exposed Zurn Elkay remains to potential funding pressure in healthcare and education construction projects...

Zurn Elkay Water Solutions' narrative projects $1.9 billion revenue and $266.9 million earnings by 2028.

Uncover how Zurn Elkay Water Solutions' forecasts yield a $55.33 fair value, a 9% upside to its current price.

Exploring Other Perspectives

ZWS 1-Year Stock Price Chart
ZWS 1-Year Stock Price Chart

Two fair value estimates from the Simply Wall St Community span roughly US$47.73 to US$55.33, underscoring how far individual views can differ. You should weigh that spread against the company’s dependence on non residential construction and consider several alternative scenarios for future project activity.

Explore 2 other fair value estimates on Zurn Elkay Water Solutions - why the stock might be worth as much as 9% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Zurn Elkay Water Solutions research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Zurn Elkay Water Solutions research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zurn Elkay Water Solutions' overall financial health at a glance.

Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • Find 53 companies with promising cash flow potential yet trading below their fair value.
  • We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.